Monitoring Time in Range helps minimize fluctuating blood sugar levels, mitigates complications of diabetes LAVAL, QC — Soon after the onset of the COVID-19 pandemic, it became increasingly evident that… Read More
Vabysmo achieved its primary endpoint of non-inferiority to aflibercept in RVO in the BALATON and COMINO clinical trials Vabysmo was generally well tolerated, with a safety profile consistent with previous trials Vabysmo is the first… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, announces it is supporting initiatives to raise… Read More
Expanded indication for REBINYN® will continue to support Canadian pediatric patients living with hemophilia B MISSISSAUGA, ON — Novo Nordisk announced today that Health Canada has approved a new indication… Read More
Leading Biotechnology Professional Brings 25+ Years of Experience to the Vancouver-Based Organization VANCOUVER, BC — Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that… Read More
